Company News
RPG Life Sciences Subsidiary Allots 40% Stake
RPG Life Sciences subsidiary RPGAP allotted 40% equity to investors ILSF and VJF for ₹243.33 crores.
The investment follows an Investment and Shareholders' Agreement executed on July 29, 2026.
RPGAP r